1ml of triamcinolone (40mg/1ml)

TERMINATED · PHASE3 · Carpal Tunnel Syndrome, De Quervains Tenosynovitis, Trigger Finger

Standard of Care change impacted recruitment

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.